Showing results (281-290 of 316) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase CD J Propper, A C McDonald, A Man, et al.
NPJ Breast Cancer|May 20, 2026
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy resultsKristina Fanucci, Mariya Rozenblit, Julia C F Quintanilha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate CancerNicolas Sayegh, Ryon P Graf, Umang Swami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2024
Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World PracticeDebra L Richardson, Julia C F Quintanilha, Natalie Danziger, et al.
Journal of Circulating Biomarkers|September 23, 2017
Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear CellsDavid Lu, Ryon P Graf, Melissa Harvey, et al.
Biomaterials Science|September 14, 2022
Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunityBrett H Pogostin, Marina H Yu, Alon R Azares, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 28, 2017
Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse SurvivalDaniel J Boffa, Ryon P Graf, Michelle C Salazar, et al.
Pageof 32